
Browsing restrictions can be lifted for a fee.
Sesoda Corporation manufactures and markets sulfate of potash (SOP) in Taiwan. The company offers standard, soluble, low chloride, granular, and industrial grade SOP products; and hydrochloric acid for use in acid washing in metallurgy and printed circuit boards, as well as manufacturing chloride chemicals and food processing. It also provides liquid calcium chloride for use in fluoride removal before waste water emission in the electronic and optoelectronic industries. In addition, the company trades in soda ash, sugar, sodium bicarbonate, sodium chloride, mixed calcium phosphate, solid calcium chloride, ammonium bicarbonate, and pearl luster pigment products. Further, it provides bulk shipping services through 6 vessels. Sesoda Corporation was founded in 1957 and is headquartered in Taipei City, Taiwan.
1708
東鹼
1.97%
(0.02)
The most recent financial report for 東鹼 (1708) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1708's short-term business performance and financial health. For the latest updates on 1708's earnings releases, visit this page regularly.
According to historical valuation range analysis, 東鹼 (1708)'s current price-to-earnings (P/E) ratio is 7.89, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 東鹼 (1708) reported an Operating Profit of 292.62M with an Operating Margin of 18.79% this period, representing a decline of 15.34% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 東鹼 (1708) announced revenue of 1.56B, with a Year-Over-Year growth rate of -3.91%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 東鹼 (1708) held Total Cash and Cash Equivalents of 2.02B, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 東鹼 (1708) achieved the “three margins increasing” benchmark, with a gross margin of 32.55%%, operating margin of 18.79%%, and net margin of 17.05%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1708's profit trajectory and future growth potential.
According to the past four quarterly reports, 東鹼 (1708)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 1.07. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
東鹼 (1708)'s Free Cash Flow (FCF) for the period is 202.34M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 34.24% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.